A review of the use of clonidine as a sleep aid in the child and adolescent population

Clinical Pediatrics

Volumn 53, Issue 3, 2014, Pages 211-216

  Nguyen, Mathew ^a   Tharani, Shalini ^a   Rahmani, Mariam ^a   Shapiro, Michael ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHEMICALLY INDUCED; CHILD; COMPLICATION; DIZZINESS; DRUG EFFECTS; FATIGUE; HEADACHE; HUMAN; SLEEP DISORDERS; SLEEP STAGE; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CLONIDINE; DIZZINESS; FATIGUE; HEADACHE; HUMANS; SLEEP DISORDERS; SLEEP STAGES; TREATMENT OUTCOME;

EID: 84894148940     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/0009922813502123     Document Type: Review

References (33)

1. Clonidine hydrochloride [package insert]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc; October2009. http://www.accessdata.fda.gov/ drugsatfda-docs/label/2009/017407s034lbl.pdf. Accessed October 12, 2012.
2. Arnsten AF, Scahill L, Findling RL. α2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data. J Child Adolesc Psychopharmacol. 2007 ; 17: 393-406
3. Hunt RD, Minderaa RB, Cohen DJ. Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Psychiatry. 1985 ; 24: 617-629
4. Kapvay (clonidine hydrochloride) extended-release tablets [package insert]. Atlanta, GA: Shionogi Pharma, Inc; September2010. http://www.kapvay. com/pdf/Kapvay-final-09.28.10.pdf. Accessed December 24, 2012.
5. Intuniv (guanfacine) extended-release tablets [package insert]. Wayne, PA: Shire US, Inc; June2011. http://pi.shirecontent.com/PI/PDFs/Intuniv-USA-ENG. pdf. Accessed December 24, 2012.
6. Kemph JP, DeVane CL, Levin GM, Jarecke R, Miller RL. Treatment of aggressive children with clonidine: results of an open pilot study. J Am Acad Child Adolesc Psychiatry. 1993 ; 32: 577-581
7. Lowenthal DT, Matzek KM, MacGregor TR. Clinical pharmacokinetics of clonidine. Clin Pharmacokinet. 1988 ; 14: 287-310
8. Croxtall JD. Clonidine extended-release in attention-deficit hyperactivity disorder. Pediatr Drugs. 2011 ; 13: 329-336
9. Catapres-TTS (clonidine) [package insert]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc; May2012. http://bidocs.boehringer-ingelheim.com/ BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/ Prescribing+Information/PIs/Catapres+TTS/CatapresTTS.pdf. Accessed December 24, 2012.
10. Delbarre B, Schmitt H. Sedative effects of alpha-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs. Eur J Pharmacol. 1971 ; 13: 356-363
11. Holman RB, Shillito EE, Vogt M. Sleep produced by clonidine (2-(2,6-dichlorophenylamino)-2-imidazole hydrochloride). Br J Pharmacol. 1971 ; 43: 685-695
12. Owens JA, Rosen CL, Mindell JA, Kirchner HL. Use of pharmacotherapy for insomnia in child psychiatry practice: a national survey. Sleep Med. 2010 ; 11: 692-700
13. Owens JA, Babcock D, Blumer J, et al. The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: rational approaches. A consensus meeting summary. J Clin Sleep Med. 2005 ; 1: 49-59
14. Trommer BL, Hoeppner JB, Rosenberg RS, Armstrong KJ, Rothstein JA. Sleep disturbances in children with attention deficit disorder. Ann Neurol. 1988 ; 24: 325-332
15. Stein MA. Unravelling sleep problems in treated and untreated children with ADHD. J Child Adolesc Psychopharmacol. 1999 ; 9: 157-168
16. Steingard R, Biederman J, Spencer T, Wilens T, Gonzalez A. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 1993 ; 32: 350-353
17. Owens JA, Rosen CL, Mindel JA. Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians. Pediatrics. 2003 ; 111 (5). e628 - e635
18. Efron D, Hiscock H, Sewell JR, et al. Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists. Pediatrics. 2003 ; 111: 372-375
19. Prince JB, Wilens TE, Biederman J, Spencer TJ, Wozniak JR. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry. 1996 ; 35: 599-605
20. Owens JA. The practice of pediatric sleep medicine: results of a community survey. Pediatrics. 2001 ; 108: E51
21. Wilens TE, Biederman J, Spencer T. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1994 ; 33: 424-426
22. Hollway JA, Aman MG. Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature. Res Dev Disabil. 2011 ; 32: 939-962
23. Ming X, Gordon E, Kang N, Wagner GC. Use of clonidine in children with autism spectrum disorders. Brain Dev. 2008 ; 30: 454-460
24. Fankhauser MP, Karumanchi VC, German ML, Yates A, Karumanchi SD. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. J Clin Psychiatry. 1992 ; 53: 77-82
25. Ingrassia A, Turk J. The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders - a case series. Eur Child Adolesc Psychiatry. 2005 ; 14: 34-40
26. Feron FJ, Hendriksen JG, Nicolai J, Vles JS. New-onset seizures: a possible association with clonidine?. Pediatr Neurol. 2008 ; 38: 147-149
27. Gutgesell H, Atkins D, Barst R, et al. AHA scientific statement: cardiovascular monitoring of children and adolescents receiving psychotropic drugs. J Am Acad Child Adolesc Psychiatry. 1999 ; 38: 1047-1050
28. Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007 ; 46: 894-921
29. Horacek HJ. Extended-release clonidine for sleep disorders. J Am Acad Child Adolesc Psychiatry. 1994 ; 33: 1210
30. Ghanizadeh A. Insomnia, night terror, and depression related to clonidine in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2008 ; 28: 725-726
31. Kappagoda C, Schell DN, Hanson RM, Hutchins P. Clonidine overdose in childhood: implications of increased prescribing. J Paediatr Child Health. 1998 ; 34: 508-512
32. Klein-Schwartz W. Trends and toxic effects from pediatric clonidine exposures. Arch Pediatr Adolesc Med. 2002 ; 156: 392-396
33. Spiller HA, Klein-Schwartz W, Colvin JM, Villalobos D, Johnson PB, Anderson DL. Toxic clonidine ingestion in children. J Pediatr. 2005 ; 146: 263-266